alexa Synthesis, of Novel Piperine Analogs of Dipeptidyl Boronic Acid as Antimicrobial and Anticancer Agents | Open Access Journals
ISSN: 2161-0444
Medicinal Chemistry
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Synthesis, of Novel Piperine Analogs of Dipeptidyl Boronic Acid as Antimicrobial and Anticancer Agents

Durvasula V.R. Venugopal1, Nagendra Sastry Yarla2 and Parimi Umadevi1*

1Department of Chemistry, Institute of Science, GITAM University, Visakhapatanam-530045, Andhra Pradesh, India

2Department of Biochemistry/Bioinformatics, School of Life Sciences, Institute of Science, GITAM University, Visakhapatanam-530045, Andhra Pradesh, India

*Corresponding Author:
Parimi Umadevi
Department of Chemistry, Institute of Science
GITAM University, Visakhapatanam-530045, Andhra Pradesh, India
Tel: +91-9490753446
E-mail: [email protected]

Received date: May 21, 2014; Accepted date: August 20, 2014; Published date: August 22, 2014

Citation: Venugopal DVR, Yarla NS, Umadevi P (2014) Synthesis, of Novel Piperine Analogs of Dipeptidyl Boronic Acid as Antimicrobial and Anticancer Agents. Med chem 4:606-610. doi:10.4172/2161-0444.1000201

Copyright: © 2014 Venugopal DVR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Medicinal Chemistry

Abstract

In the present study three piperine analogs of dipeptidyl boronic acid (1 to 3) were synthesized and evaluated the antimicrobial and anticancer activities. Chemical structures of the synthesized compounds were characterized by 1H, 13C and mass spectral studies. All the compounds were screened for their antineoplastic activity on HeLa cervical, MCF-7 breast and MIA PaCa-2 pancreatic cancer cell lines and antimicrobial activity against seven bacterial and five fungal species. In vitro results showed that most of the compounds displayed moderate to good inhibitory activity on the tested cancer cell lines, among them compound 1 showed good anticancer activity where as Compound 3 was found to be potent antimicrobial agent against Asperigillus fumigates at a concentration of 62 μg/mL than other tested compounds and the parent molecule piperine. All the compounds were subjected to molecular docking studies on Leucyl-tRNA synthase as well as for 20S proteasome inhibition. In silico molecular docking results demonstrated that all compounds had low binding energy toward the active pocket and thus they may act as a good Leucyl-tRNA synthase inhibitor.

Keywords

Piperine; Piperic acid; Boronic acids; Anticancer activity; Antibacterial activity

Introduction

Boronic acids have been illustrious in the literature back in 1860 [1], developing over the years into a wide studied area of chemistry. After the approval of Velcade® as proteasome inhibitor, boronic acids have emerged as a unique lead for several malignant tumors, as β-lactamase inhibitors, NS3 protease inhibitors, amino-acyl tRNA synthase inhibitors, and anticoagulants. Boronic acids and its derivatives have gained outstanding importance as a result of their wide-spread biological activity and their use in synthetic chemistry. Piperine, alkaloid from Piper nigrum L found to display an ample spectrum of pharmacologic activities, together with antimicrobial [2] and antineoplastic properties [3,4]. Despite the acclaimed potential of piperine, up to now there are few reports available for piperine based antimicrobial and antineoplastic agents. Recent development of conjugate molecules between natural products and synthetic molecules emerged as a new approach in the discovery of novel bioactive agents. Piperine amides or piperine ester analogs were potential cytotoxic agents against different neoplastic cell lines than the parent compound piperine. The activity of piperine lies mostly within the amide linkage [5]. Piperine enhances bioavailablity of drugs [6]; this prompted us to synthesize piperine derivatives of dipeptidyl boronic acid. Encouraged from our antecedent research, we wish to further exploit amide linkage of piperine to get a better antineoplastic and antimicrobial agent.

In modern drug designing, molecular docking is commonly acclimated for understanding drug-receptor interaction. Onychomycosis is a fungal infection of toenails and fingernails that still remains tough to treat. It is acquired primarily by dermatophytes, a category of fungus that dwells on skin, hair, and nails [7]. There are few treatments accessible, and thus they have poor clinical affectivity and lot of safety considerations [8]. The enzyme, particularly LeucyltRNA synthase, is a new target for antifungal. Leucyl-tRNA synthase is a cytoplasmatic enzyme; activate the ATP-dependent ligation of L-leucine to tRNA (Leu). Boronic acid activity on Asperigillus fumigatus is explained by inhibition of active sites in Leucyl-tRNA synthase inhibiting mechanism. All the compounds were subjected to molecular docking studies for Leucyl-tRNA synthase inhibition. In order to find out the effect of conjugated double bond present in piperine for its biological activity, we synthesized the tetrahydro and tetrabromo piperine analogs of peptidyl boronic acid. We achieved to a conclusion that increase in number of halogen atoms accrued antifungal activity on Asperigillus fumigates. Hydrogenation of double bond in piperine lowered anticancer activity. Piperine-boronic acid conjugate has higher antineoplastic activity than the parent molecule piperine and could be a promising lead [9,10].

Experimental

Chemistry

General: Commercially available reagents were used directly without any purification unless otherwise stated. Reaction progress was monitored by silica gel aluminum sheets (60F-254) and RP- 18 F254s using UV light as a visualizing agent and 15% ethanolic phosphomolybdic acid and heat or ninhydrin and heat as developing agent. The 200-300 mesh silica gel was used for column purification. 1HNMR and 13CNMR spectra were recorded on Bruker Avance 400 spectrometer with TMS as internal standard. Splitting patterns are described as singlet (s), doublet (d), triplet (t), quartet (q), broad (br), or doublet of doublet (dd). The value of chemical shifts (δ) is given in ppm and coupling constants (J) in Hertz (Hz). Mass spectra were obtained using Agilent LC-MS instrument in electrospray positive and negative ionization modes. Starting materials used in the synthesis of the compounds of the invention include N-protected amino acids procured from chemical suppliers with purity not less than 99%.

α-aminoacyl phenylalanine pinanediol boronic ester was prepared according to the known procedure.

Extraction and Isolation of piperine: 200 g of ground black pepper powder was taken in a 1 liter round bottomed flask and 500mL of 95% ethanol is added and refluxed for 2 h. The mixture is filtered and concentrated by rotator evaporator 20 mL of 10% ethanolic KOH solution was added. The resulting solution is heated for ten minutes and water is added drop wise and further it was allowed to stand overnight. A yellow precipitate separated out. The solid precipitate is filtered and recrystallised with 10-20 mL of acetone to obtain 6 g of piperine.

Synthesis of Piperic acid from Piperine (Scheme-1): 5 g of Piperine (17.5 mmol) is refluxed with methanolic KOH (2 N, 20 mL) for 6 h and methanol was evaporated under reduced pressure, the solution was cooled in ice bath. The gummy potassium salt of piperic acid was suspended in water and gradually acidified with dil. HCl; dark yellow precipitate was collected and stirred for 3-4 h in the cold ice bath, filtered and washed with cold water. The compound was recrystallised from methanol yielding yellow crystalline compound with 80% yield.

medicinal-chemistry-piperine-dipeptidyl

Scheme 1: Synthesis of piperine dipeptidyl boronic acid- analogs.

Synthesis of tetrahydro piperic acid (Scheme-1): To a solution of piperic acid (1 m.mol.) in ethanol, ammonium formate (10 m.mol.) and 10% Pd/C (5 mol %) were added, the mixture was stirred at 20- 25°C for 2 h and concentrated under vaccum. To the concentrated reaction mixture dichloromethane was added, the organic layer was washed with water, dried over anhydrous magnesium sulphate and concentrated to get tetrahydropiperic acid.

Synthesis of tetrabromo piperic acid (Scheme-1): 2 m.mol of Bromine in dichloromethane is added to a solution of piperic acid (1 m.mol.) in 10 mL dichloromethane. The reaction mixture was stirred at 20-25°C until completion of the reaction. The solvent is evaporated under vacuum to get tetrabromopiperic acid.

General synthesis of piperine analogs of di peptidyl -boronic acid 1-3(Scheme-1)

Stage 1: piperine analogs of peptidyl boronic ester

To a solution (1 m.mol.) of piperic acid (for compound 1) or tetrahydro piperic acid (for compound 2) or tetrabromo piperic acid (for compound 3) in 20 mL of dry dichloromethane hydroxy benzotriazole (HOBt) (0.6 m.mol.) and α-aminoacyl phenylalanine pinanediol boronic ester (1 m.mol.) were added. The contents were cooled to 0-5°C, 1-Ethyl-3-(3-dimethyllaminopropyl) carbodiimide hydrochloride (EDC.HCl) (1 m.mol.) and N, N-diisopropylethylamine (DIPEA) (1 m. mol.) were added. The reaction mixture was maintained at 20-25°C for completion. After completion of reaction the contents were washed with water (10 mL) followed by washing twice with aqueous solution of 1% H3PO4 (10 mL) and twice with aqueous solution of 2.5% K2CO3 (10 mL). The resultant organic layer is concentrated under reduced pressure to get corresponding dipeptidyl boronic ester.

Stage 2: piperine analogs of di peptidyl boronic acid

The above obtained dipeptidyl boronic esters were dissolved in a mixture of (10 mL) methanol, (10 mL) hexane, isobutylboronic acid (1 m.mol.) followed by (10 mL) 1N HCl (aq) solution and stirred at 25-30°C till the completion of the reaction. The aqueous layer was concentrated to remove methanol and was extracted with dichloromethane (10 mL) to get the product. The extracted compound was purified by column chromatography over silica gel (100-200 mesh) with DCM: Hexane mixture to get pure compounds 1-3.

The organic layer above obtained is purified to get the starting material isobutyl boronic acid pinanediol ester, to recycle the expensive (+) pinanediol completely.

Characterization of synthesized compounds: Nα-[(2E,4E)- 5-(1,3-benzodio/ xol-5-yl) penta-2,4-dienoyl]-N-[(1R)-1- (dihydroxyboranyl)-3-methylbutyl]-L-phenylalaninamide (Compound 1): Yield: 80%, 1H-NMR (400 MHz):7.2-7.4( 4H,m), 6.9(1H,s), 6.8(1H, d), 6.78(2H,m), 6.6(1H,m), 6.4(1H, brs), 6.1(1H,brs), 5.97(2H,s), 5.93(1H,d), 4.7(1H,m), 4.28(1H,d,j=8.2 Hz), 3.32(3H,m), 2.35(1H,m), 2.2(1,m), 2.03(1H,t), 1.7-2(4H,m), 1.4-1.6(2H,m)1.37(2H,m), 1.2(2H,m), 1.25(2H,m), 1.1-1.2(2H,m), 0.97(6H,t).

13C-NMR (400 MHz): 173.48 (C=O), 167.56 (C=O), 148.1, 141.54, 138.35 (CH=CH), 129.52, 128.3, 128.97, 108.34, 101.17(O-CH2-O), 56.01(N-C-C=O), 53.2 (C-B), 39.94 (-CH2-Ph), 27.14, 22.9 (-CH3).M/z: 478.3

Nα-[5-(1,3-benzodioxol-5-yl)pentanoyl]-N-[(1R)-1- (dihydroxyboranyl) -3-methylbutyl] -L-phenylalaninamide (Compound 2): Yield: 78%, 1H-NMR (400 MHz): 7.17 (1H, m), 7.07 (2H, m), 6.93(2H, m), 6.7(3H,m), 5.91(2H, m), 5.5(2H, brs), 4.6(1H,m), 3.65(1H,m), 3.07(2H,m), 2.54(2H, t), 2.2(2H, t, j=8Hz), 1.82(1H, m), 1.7(2H, m), 1.64(2H,m), 1.24(1H,m), 1.44(1H,m), 0.9(6H,t). 13C-NMR (400 MHz): 173(C=O), 148.1, 146.1, 137.4, 136.8, 129.21, 128.6, 128.2, 121.1, 108.8, 108.1, 100.68 (O-CH2-O), 54.26, 52.84, 39.94, 38.36, 36.55, 34.47, 29.84, 27.14, 25.09, 22.9. M/z: 482.3

Nα-[5-(1,3-benzodioxol-5-yl)-2,3,4,5-tetrabromopentanoyl]-N- [(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-phenylalaninamide (Compound 3): Yield: 66%, 1H-NMR (400 MHz): 7.2(1H, m), 7.15(1H, m), 7.09(1H, m), 7.07(1H, m), 6.93(1H, m), 6.88(1H, m), 6.6(1H, brs), 6.48(1H, brs), 5.9(2H,s), 5.44(1H, d, j=8Hz), 5.24(1H, dd), 5.02(1H, brs), 5.04(1H, d, j=12 Hz), 4.9(1H, dd), 4.7(1H,m), 3.64(1H, m), 3.1(2H, m), 1.82(1H, m), 1.45(1H, m), 1.25 (1H, m), 0.9(6H,s). 13C-NMR (400 MHz): 172.56 (C=O), 165.38 (C=O), 149.18 (Aromatic), 147.07, 136.57, 130.58, 129.3, 128.6, 128.2, 122.64, 109.29, 108.02, 101.13, 59.02, 56.13, 55.8 (CH-Br), 53.2, 52.8 (CH-B), 49.1, 39.3, 38.1 (CH2-Ph), 27.1, 22.9 (CH3); M/z: 797.4.

Bioactivity Studies

In vitro anticancer studies

Cell lines and Cell Culture: Carcinoma of the cervix (HeLa) cells, MCF-7 breast and MIA PaCa-2 pancreatic cancer cells were maintained in Dulbecco’s modified essential medium (DMEM) supplemented with 4.5 g/L glucose, 2 mM L-glutamine and 5% fetal bovine serum (FBS) (growth medium) at 37°C in 5% CO2 incubator.

MTT assay: The MTT assay developed by Mosmann was modified and used to determine the inhibitory effects of test compounds on cell growth in vitro. In brief, the trypsinized cells from T-25 flask were seeded in each well of 96-well flat-bottomed tissue culture plate at a density of 5x103 cells/well in growth medium and cultured at 37°C in 5% CO2 to adhere. After 48h incubation, the supernatant was discarded and the cells were pretreated with growth medium and were subsequently mixed with different concentrations of test compounds (32, 64, 128, 256 and 500 μg/mL) in triplicates to achieve a final volume of 100 μL and then cultured for 48 h. The compound was prepared as 1.0 mg/mL concentration stock solutions in PBS. Culture medium and solvent are used as controls. Each well then received 5 μL of fresh MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 0.5 mg/mL in PBS followed by incubation for 2 h at 37°C. The supernatant growth medium was removed from the wells and replaced with 100 μL of DMSO to solubilize the colored Formosan product. After 30 min incubation, the absorbance (Optical Density) of the culture plate was read at a wavelength of 570 nm on an ELISA reader, Anthos 2020 spectrophotometer. The IC50 values are calculated and the results are tabulated in Table 1.

Compound Breast cancer Cervical cancer pancreatic cancer
1 64 ± 0.5 33 ± 0.3 31 ± 0.3
2 104 ± 0.2 48 ± 0.1 53 ± 0.4
3 201 ± 0.3 256 ± 0.2 301 ± 0.6
Piperine 99 ± 0.2 69 ± 0.3 110 ± 0.5

Table 1: Determination of Anticancer activity IC50* in μM.

Determination of Antibacterial activity: One hundred micro liters suspension containing 108 CFU/mL of bacteria was inoculated on the surface of Muller-Hinton agar medium (MHA) plates. The compound dissolved in 2% DMSO served as negative control and Ampicillin was used as a standard reference to determine the sensitivity of each microbial species tested for antibacterial. The Minimum Inhibitory Concentrations (MIC) of the compounds were estimated as per the guidelines of clinical laboratory standard. Bacterial suspensions were prepared by suspending the cultures grown for 24h in sterile normal saline. The turbidity of the bacterial suspension was adjusted to McFar land standard of 0.5 which is equivalent to 1.5x108CFU/mL. Two fold serial dilution of each compound was prepared in MHA. The MIC of the compounds (1-3) ranged between (50-500 μg/mL). The antimicrobial activities of the synthesized compounds were tested against Escherichia coli, Klebsiella pneumoniae, Pseudomonas Aeruginosa, Bacillus subtilis, Salmonella typhi, Shiegella dysenteriae, Staphylococcus Aureus. The results are shown in Table 2.

Compound S.aureus S.pyogenes E.coli C.koseri K.oxytoca K.pneumoniae S.dysentriae S.typhi C.fruendi P.aeruginosa
1 2.5 2.5 0.6 1.25 0.6 0.6 0.6 1.25 2.5 2.5
2 2.5 2.5 0.6 1.25 0.6 0.6 0.25 2.5 1.25 2.5
3 1.25 0.6 0.6 0.25 0.25 0.25 0.6 0.25 0.6 1.25
Piperine 1.25 1.25 0.3 0.9 0.4 0.2 0.6 1.25 1.25 1.25

Table 2: Determination of Antibacterial Activity (MIC mg/ml).

Minimum Inhibitory Concentration (MIC): MIC was determined by serial dilution method. Two fold serial dilutions of test compounds were carried out in nutrient broth. To each test tube 105 CFU/mL of active bacterial cultures were inoculated. Piperine was used as reference drug. The culture tubes were incubated at 37°C for 24h. After the incubation the tubes were checked for bacterial growth and the MIC was determined and expressed in mg/mL.

Antifungal screening: Sterile 96-well polystyrene microtitre plates with well capacities of 300 μL were used and 100 μL of fresh Mueller Hinton broth were added to each well of the plate. One hundred microlitres of the compound stock solution were added to each well of the first column. Then, 100 μL of the solution were removed from the first column and mixed thoroughly with the broth in the corresponding wells of the second column. Subsequently, a 100 μL aliquot was removed from each well in this column and mixed with contents of the corresponding well of the next column. This doubling dilution was performed in all rows across the plate. One row was used as a positive control and contained an antimycotics nystatin and fluconazole to determine the sensitivity of fungal species. The other row contained the solvent (DMSO) as a negative control. In each well of the plate 10 μL of fungi cultures (105 spores per mL) were inoculated. The microtitre plate was incubated at 37°C for 48 h for fungi. After that, fungi growths were measured. The MIC was determinate as the lowest concentration that resulted in inhibition of fungal growth. The results are tabulated in Table 3.

Compound Asperigillus flavus Asperigillus fumigatus Asperigillus niger Pencillium spp Candida albicans (5  Isolates)
1 0.6 2.5 1.25 0.6 0.25-1
2 0.12 0.25 0.12 0.25 0.31-1.25
3 0.25 1.2 0.5 0.25 0.25-1
Piperine 0.3 0.6 0.6 0.6 0.5-1

Table 3: Determination of Antifungal Activity (MIC mg/ml).

Docking and comparison with the experimental data: The 3D Crystal structure of ligand free yeast 20S proteasome (PDB id: 3BDM), ligand free Thermus thermophiles Leucyl-tRNA synthase (PDB id: 2BTE) were obtained from RCSB, PDB database (www.rcsb.org). The protein is validated using Procheck and what if sever. The core structures of all ligands were predicted and sketched using ISIS draw software. They were geometrically optimized and energy minimized on to 3D structure using Dundee PRODRG-2 server and retrieved in PDB format for docking. The docking studies of all the synthesized compounds were carried out in Molegro Virtual Docker.

Protein-ligand interactions were carried out in Molegro virtual docker. The missing bond orders, hybridization and charges were assigned to the protein which is implemented in the program itself. Potential binding sites were detected using cavity detection algorithm and docking was performed.. The cavity docking procedure was carried with an energy grid resolution of 0.30 A° taking the default parameters. The algorithm Mol Dock SE includes total number of runs as 10, population size of 50 and the Maximum Interactions -1500. The output was visualized in Molegro Virtual docker as per Figures 1 to 3.

medicinal-chemistry-backbone-structure

Figure 1: Interaction of compound1 with protein 2BTE; protein shown in backbone structure and ligand in green color.

medicinal-chemistry-protein-wireframe

Figure 2: Interactions of Compound 2 with protein in wireframe form with hydrogen bondings in blue color.

medicinal-chemistry-Electrostatic-interaction

Figure 3: Electrostatic interaction of compound 2 with protein.

We have docked different sets of piperine-dipeptidyl boronic acid analogs. Based on the primary model with compound 1 we have designed the analogs. The results are tabulated in Table 4.

Dock Score (Kcal/mol)
Compound Leucyl t-RNA synthase Yeast 20S proteasome
(2BTE) (3BDM)
1 -99.98 -180.9
2 -115.96 -164.65
3 -98.47 -166.56
Piperine -88.9 -109.51
α-aminoacyl phenylalanine  pinanediolboronic ester -101.5 -121.9

Table 4: Determination of Moldock scores of Piperine-boronic acid analogs on proteins Dock.

Results and Discussion

Chemistry

Piperine was extracted from the dried seeds of piper nigrum, converted into acid by hydrolysis using ethanolic-KOH and con.HCl. The acid is condensed with amine group of α–aminoacyl phenylalanine pinanediol boronic acid in dichloromethane with EDC.HCl (1-Ethyl- 3-(3-dimethylaminopropyl) carbodiimide.HCl). EDC.HCl was chosen as coupling agent because of its selectivity, and the water soluble byproduct, which can be washed away to administer the pure product. The piperidine amide of natural piperine was replaced with α-aminoacyl phenylalanine boronic acid to get compounds (1-3). All the tested compounds (1-3) were characterized by 1H, 13C NMR and LC-MS analysis. IR spectrum of the compounds showed absorption at 1578- 1657cm-1 due to amide bond C=O stretching frequency; the 1H-NMR values of δ2.97-δ3.58 is due to (-HC-B ) the value at δ4.91-δ5.1 in dipeptidyl boronic acids is due to(-N-CH-CO).

Biological activity

The cytotoxic activity was carried out by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and results were presented in Table 1. Compound 1, piperine analog of dipeptidyl boronic acid was superior to the other two compounds with an IC50 as low as 3 1+0.3 μM against pancreatic cancer cell line.

The antibacterial assay was carried out by the consecutive dilution method and the MIC values were recorded and abbreviated in Table 2. Among the entire tested compounds, compound 3 containing tetrabromo piperic acid was found to be best antibacterial against K.pneumoniae. The MIC values of all most all the tested compounds were comparable to piperine.

To actuate the antifungal activity of these compounds, we screened for their minimum inhibitory concentration (MIC) against a wide array of fungal strains (Table 3). Our initial lead was Piperine analog of dipeptidyl boronic acid (1) showed a modest activity against Asperigillus fumigates. To increase its activity the lead was reduced to get tetrahydro derivative (2), and brominated to get tetrabromo derivative (3). Compound 2 showed lowest MIC value means good antifungal activity.

The docking studies of all the synthesized compounds were agitated out in Molegro virtual docker and the binding energies are represented in Table 4. The structures of the docked compounds were represented in Figures 1 to 3, with receptor ligand interactions. After antecedent screening the compounds with a higher docking score than piperine were synthesized.

Discussion

A total of three piperine analogs of dipeptidyl-boronic acid were synthesised and subjected to docking analysis. The compounds were evaluated for anti microbial and anti neoplastic activity. The anti-neoplastic activity of Piperine analog of dipeptidyl-boronic acid (compound-1) was best among all the tested compounds. The antimicrobial activity of compound-2 containing tetrabormopipericacid nucleus was found to be best against K.pneumoniae. The insilico results are in concordance with invitro results.

Conclusions

A total of three piperine dipeptidyl-boronic acid conjugates were designed and synthesized. They were subjected to molecular docking to estimate their binding efficiency. All the synthesized compounds possess antimicrobial as well as antineoplastic properties. However, the presence of halogen as hetero atom enhanced the ligand protein binding interaction among the synthesized piperine-boronic acid conjugates. In silico studies are in concordance with in vitro studies. Compound 3, that apparently accomplished higher binding affinity showed the lowest MIC values for all the tested organisms ( MIC ranging from 0.25-2.5 μg/mL). We also found that reduction of the double bonds in piperine resulted in lower anticancer activity; bromination of the double bonds further decreased the anticancer activity in contrast we found that the reduction of double bonds or bromination of double bonds enhanced the antimicrobial activity. We conclude analogs of piperine-dipeptidyl boronic acids were superior to piperine with respect to both cytotoxic and antimicrobial properties which paves a way for the synthesis of novel therapeutics.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12031
  • [From(publication date):
    September-2014 - Oct 22, 2017]
  • Breakdown by view type
  • HTML page views : 8220
  • PDF downloads :3811
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords